Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis
This study has been withdrawn prior to recruitment.
( Insufficient funds available )
Study NCT00603785   Information provided by University of California, San Francisco
First Received: January 11, 2008   Last Updated: April 16, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Sinusitis
Additional conditions recognized in this trial
Chronic Disease
Sinusitis
More general conditions related to this trial
Disease Attributes
Nose Diseases
Otorhinolaryngologic Diseases
Paranasal Sinus Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Placebo
Xolair
Sponsors listed in this trial
University of California, San Francisco
University of Chicago


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services